A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL).
Company profile
Ticker
EDAP
Exchange
Website
CEO
Marc Oczachowski
Employees
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
SEC CIK
Corporate docs
EDAP stock data
News
12 Health Care Stocks Moving In Monday's Intraday Session
18 Jul 22
EDAP Announces Focal One HIFU Reimbursement Raised To Urology APC Level 6 Under CMS Outpatient Prospective Payment System Proposed Rule For CY23
18 Jul 22
Earnings Scheduled For May 17, 2022
17 May 22
Earnings Preview: Edap TMS
16 May 22
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
16 May 22
Calendar
8 Apr 22
9 Aug 22
31 Dec 22
Financial summary
| Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q1 2022
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0 |
| Total shares | 0 |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Financial report summary
?Competition
Elbit ImagingContent analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accommodation, Africa, animal, Asian, Belarusian, binding, broadly, climate, compensatory, directeur, disappoint, disinterested, divested, domain, Doppler, dramatically, ESG, existingdistribution, fall, forgiven, formatted, Franceare, geopolitical, hand, horizon, hyperplasia, Inline, instability, Labtau, Linkbase, Majesty, mechanical, mesenteric, Morgan, Munich, Myanmar, parenchyma, persist, popular, port, reclassified, recycling, Ref, Rulemaking, Russian, Ryan, Schema, Stanley, superior, supranational, Taxonomy, tie, vast, vivo, week, XBRL, yearly
Financial reports
Current reports
6-K
Current report (foreign)
9 Jun 22
6-K
Current report (foreign)
17 May 22
6-K
Current report (foreign)
30 Mar 22
6-K
Current report (foreign)
17 Nov 21
6-K
Current report (foreign)
25 Aug 21
6-K
Current report (foreign)
11 Jun 21
6-K
EDAP Reports First Quarter 2021 Results and Provides Operational Update
11 May 21
6-K
Current report (foreign)
26 Apr 21
6-K
Current report (foreign)
23 Apr 21
6-K
Current report (foreign)
22 Apr 21
Registration and prospectus
S-8
Registration of securities for employees
18 Nov 21
S-8
Registration of securities for employees
28 Sep 21
S-8
Registration of securities for employees
16 Jun 21
424B5
Prospectus supplement for primary offering
23 Apr 21
FWP
Free writing prospectus
22 Apr 21
424B5
Prospectus supplement for primary offering
22 Apr 21
F-3
Shelf registration (foreign)
7 Apr 21
S-8
Registration of securities for employees
4 Apr 17
424B5
Prospectus supplement for primary offering
7 Apr 16
424B5
Prospectus supplement for primary offering
28 May 14
Proxies
No filings
Other
EFFECT
Notice of effectiveness
19 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
UPLOAD
Letter from SEC
13 Apr 21
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
2 Apr 17
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3 Apr 16
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Apr 15
EFFECT
Notice of effectiveness
6 May 14
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
2 Apr 14
UPLOAD
Letter from SEC
20 Nov 13
CORRESP
Correspondence with SEC
14 Nov 13
Ownership
SC 13G/A
EDAP TMS / Soleus Capital Master Fund ownership change
10 Feb 22
SC 13G
EDAP TMS / MORGAN STANLEY ownership change
10 Feb 22
SC 13G
EDAP TMS / Soleus Capital Master Fund ownership change
27 Apr 21
SC 13G/A
EDAP TMS / Opaleye Management ownership change
12 Feb 21
SC 13G/A
Edap TMS Sa
14 Feb 20
SC 13G
Edap TMS Sa
7 Nov 19
SC 13G
Edap TMS Sa
11 Apr 16
SC 13G/A
Edap TMS Sa
3 Apr 16
SC 13G/A
Edap TMS Sa
15 Nov 15
SC 13G/A
Edap TMS Sa
11 Jan 15
Reddit threads
Daily Discussion Thread - May 17th, 2022
17 May 22
Daily Discussion Thread - May 16th, 2022
16 May 22
Daily Discussion Thread - May 10th, 2022
10 May 22
Daily Discussion Thread - May 9th, 2022
9 May 22
Daily Discussion Thread - March 30th, 2022
30 Mar 22
Daily Discussion Thread - March 29th, 2022
29 Mar 22
Daily Discussion Thread - March 28th, 2022
28 Mar 22
Daily Discussion Thread - November 17th, 2021
17 Nov 21
Daily Discussion Thread - November 16th, 2021
16 Nov 21
Daily Discussion Thread - November 15th, 2021
15 Nov 21